PRN News Releases

The study involved end-stage oncology patients with no other suitable treatment options.In this Phase Ib study, Pidnarulex (CX-5461) demonstrated acceptable clinical tolerability and showed preliminary signs of efficacy, even in patients who had previously failed treatment with PARP inhibitors.Out of 15 patients who were evaluable for drug response, 40% achieved clinical benefit, with stable disease (SD) being the best therapeutic response observed.TAIPEI and SAN DIEGO, Sept. 8, 2024 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company dedicated to developing fir...

(Steady international business growth brought overseas revenue accounting for 62.23% of its core business revenue)...

SINGAPORE, Sept. 8, 2024 /PRNewswire/ -- JST Digital, a global financial services firm specializing in digital assets, today announced that its Singapore subsidiary, JST Digital & Technology Pte. Ltd. ("JST Singapore") has received an in-principle approval for a Major Payment Institution (MPI) licence from the Monetary Authority of Singapore (MAS) to provide digital payment token service....

OCI Global ("OCI", the "Company") has entered into a binding equity purchase agreement for the sale of 100% of its equity interests in its Global Methanol Business ("OCI Methanol") to Methanex Corporation ("Methanex"), (the "Transaction").Purchase price consideration of USD 2.05 billion on a cash-free and debt-free basis ("Enterprise Value" or "Transaction Consideration") following a competitive process.The Transaction Consideration will be paid through a combination of approximately USD 1.15 billion of cash (taking into account expected net indebtedness) subject to customary closing adjustm...

TOKYO, Japan, Sept. 8, 2024 /PRNewswire/ -- SalesNow Inc. (Headquarters: Shibuya, Tokyo; CEO: Koki Muraoka; hereinafter "SalesNow"), a provider of the powerful sales database "SalesNow," has announced the "2024 Japan Startup Growth Companies Ranking TOP 100" based on data from Japan's largest database, "SalesNow DB (https://salesnow.jp/db)," which covers information on 5.4 million domestic companies....

BOSTON, Sept. 8, 2024 /PRNewswire/ -- Antennova, a clinical-stage biotech company focused on oncology today announced that it will present the latest data of CD73 small molecule inhibitor ATN-037 in a Mini Oral presentation at the 2024 European Society of Medical Oncology Congress (ESMO Congress 2024), taking place from September 13th to September 17th at the Fira Barcelona Gran Via in Barcelona, Spain....

ROCKVILLE, Md. and SUZHOU, China, Sept. 8, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for malignancies, today announced that it will present the latest clinical data of olverembatinib (HQP1351), the company's novel drug candidate, in patients with succinate dehydrogenase- (SDH-) deficient gastrointestinal stromal tumor (GIST), in a Mini Oral at the 2024 European Society of Medical Oncology (ESMO) Congress....

Abstract Released for E7386, Created Through Collaborative Research Between Eisai and PRISM ...

BEIJING, Sept. 8, 2024 /PRNewswire/ -- The 2024 Summit of the Forum on China-Africa Cooperation (FOCAC) was successfully held in Beijing from September 4 to 6. It took place at a critical juncture when the world is grappling with various regional and global crises and there is a pressing need for countries from the Global South to join hands. How does this year's FOCAC elevate ties between China and Africa? What is the significance of building a high-level China-Africa community with a shared future? The Global Times (GT) interviewed a number of former officials and pundits from various Afri...

BERLIN, Sept. 8, 2024 /PRNewswire/ -- Toshiba, a brand renowned for its over a century of excellence in craftsmanship and design, proudly presents the launch of its latest high-end offering, the Masterstroke Series, at the IFA 2024 in Berlin, Germany. This series marks a significant milestone in the evolution of Toshiba's product line, blending Eastern aesthetics with cutting-edge technology to create an unparalleled living experience....

RIYADH, Saudi Arabia, Sept. 8, 2024 /PRNewswire/ -- Ahead of the Global AI Summit (GAIN) this week, H.E. Dr. Abdullah bin Sharaf Alghamdi, Chairman of the Saudi Data and AI Authority (SDAIA), gave a preview of Saudi Arabia's landmark AI event, which will address the Now, Next and Never for this rapidly evolving technology....

...

LOS ANGELES, Sept. 8, 2024 /PRNewswire/ -- Resecurity, a global leader in cybersecurity solutions protecting Fortune 100 corporations and government agencies worldwide, is pleased to announce a strategic partnership with Mannai Trading Co., a member of Mannai Corporation QPSC, one of Qatar's most diversified and innovative companies in information technology field. This collaboration signifies a pivotal advancement in enhancing cybersecurity infrastructure and digital protection across various sectors in Qatar....

NEW YORK, Sept. 8, 2024 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of C3.ai, Inc. ("C3.ai" or "the Company") (NYSE: AI). Investors who purchased C3.ai securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/AI....

NEW YORK, Sept. 8, 2024 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against GitLab Inc. ("GitLab" or "the Company") (NASDAQ: GTLB) and certain of its officers....

NEW YORK, Sept. 8, 2024 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lions Gate Entertainment Corporation ("Lionsgate" or "the Company") (NYSE: LGF.A; LGF.B). Investors who purchased Lionsgate securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/lgf....

NEW YORK, Sept. 8, 2024 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Verve Therapeutics, Inc. ("Verve Therapeutics" or "the Company") (NASDAQ: VERV) and certain of its officers....

NEW YORK, Sept. 8, 2024 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Xiao-I Corporation ("Xiao-I" or "the Company") (NASDAQ: AIXI). Investors who purchased Xiao-I securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/AIXI....

NEW YORK, Sept. 8, 2024 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against ZoomInfo Technologies, Inc. ("ZoomInfo" or "the Company") (NASDAQ: ZI) and certain of its officers....

SAR satellites and data enable Greece to monitor their areas of interest and improve their natural catastrophe detection and maritime awareness capabilities....